Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Buy
68

MEDP
Medpace Holdings

Last Price:
395.88
Seasonality Move:
14.22%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Medpace Holdings Price Quote

$395.88
-0.05 (1.57%)
(Updated: April 27, 2024 at 6:12 AM ET)

Medpace Holdings Key Stats

Buy
68
Medpace Holdings (MEDP) is a Buy

Day range:
$388.88 - $397.17
52-week range:
$195.03 - $421.00
Dividend yield:
0%
P/E ratio:
44.59
P/S ratio:
6.41
P/B ratio:
18.27%

Volume:
144.6K
Avg. volume:
237.7K
1-year change:
94.15%
Market cap:
$12.3B
Revenue:
$1.9B
EPS:
$9.81

How Much Does Medpace Holdings Make?

Is Medpace Holdings Growing As A Company?

  • What Is Medpace Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.18%
  • What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.41%

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went down by -1.69% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 94.15% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Is It Risky To Buy Medpace Holdings?

  • How Much Debt Does Medpace Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medpace Holdings Have?
    Cash and short term investments quarterly total is $407M
  • What Is Medpace Holdings’s Book Value Per Share?
    Book value per share is 21.67

Is Medpace Holdings Cash Flow Positive?

  • What Is MEDP Cash Flow From Operations?
    Cash flow from operations (TTM) is $506M
  • What Is Medpace Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$122.3M
  • What Is Medpace Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$22.6M

Medpace Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDP return on invested capital is 59.87%
  • What Is Medpace Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 20.18%
  • What Is MEDP Return On Equity?
    ROE is a measure of profitability and is 64.05%

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • Candel Therapeutics Inc (CADL)
    • Avid Bioservices Inc (CDMO)
    • Charles River Laboratories International Inc (CRL)
    • Iovance Biotherapeutics Inc (IOVA)
    • Renovaro Inc (RENB)

Medpace Holdings Dividend Yield

Data Unavailable

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 40.97% 29.16%
Revenue: 17.73% -0.19%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 1
Price Target: 418.90
Upside from Last Price: 5.8%

Major Shareholders

  • How many MEDP shares are owned by institutional investors?
    291.6M MEDP shares are owned by institutional investors
  • How many MEDP shares are owned by insiders?
    902.8K MEDP shares are owned by insiders